Michael A Jarvis

Title: Michael A Jarvis: Innovator in Cytomegalovirus Research

Introduction

Michael A Jarvis is a prominent inventor based in Portland, OR (US). He has made significant contributions to the field of virology, particularly in the development of recombinant cytomegalovirus vectors. With a total of 3 patents, his work focuses on innovative approaches to treat infectious diseases and cancer.

Latest Patents

Jarvis's latest patents include groundbreaking research on recombinant human cytomegalovirus (HCMV) and rhesus cytomegalovirus (RhCMV) vectors. These vectors encode heterologous antigens, which can be utilized for the treatment or prevention of infectious diseases and cancer. The recombinant vectors are designed to elicit and maintain high levels of cellular immune responses specific to the heterologous antigens while incorporating deletions in genes essential for CMV replication and dissemination.

Career Highlights

Michael A Jarvis is affiliated with Oregon Health & Science University, where he continues to advance his research in virology. His innovative work has positioned him as a key figure in the development of therapeutic strategies against viral infections and cancer.

Collaborations

Throughout his career, Jarvis has collaborated with notable scientists, including Louis Picker and Jay A Nelson. These partnerships have further enhanced the impact of his research in the scientific community.

Conclusion

Michael A Jarvis is a distinguished inventor whose work in recombinant cytomegalovirus vectors has the potential to revolutionize treatments for infectious diseases and cancer. His contributions to the field are invaluable and continue to inspire future innovations.